Novel alternative methods for the delivery of drugs for the treatment of asthma

Advanced Drug Delivery Reviews

Volumn 55, Issue 7, 2003, Pages 793-805

  Chan, Hak Kim ^a   Chew, Nora Y K ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Carrier blend; Dry powder aerosol formulation; Dry powder inhaler; Milling; Powder production process; Powder properties; Solvent precipitation; Spray drying

Indexed keywords

AEROSOLS; DRUG PRODUCTS; HYDROPHILICITY; MORPHOLOGY; PATENTS AND INVENTIONS; PULMONARY DISEASES; TERNARY SYSTEMS;

BINARY POWDER SYSTEM;

RESPIRATORY THERAPY;

LACTOSE; NEDOCROMIL SODIUM; SALBUTAMOL SULFATE;

AEROSOL; AIRFLOW; ASTHMA; CLINICAL TRIAL; CONFERENCE PAPER; CRYSTALLIZATION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRY POWDER; EVAPORATION; HUMAN; HYDROPHOBICITY; INHALER; NANOTECHNOLOGY; PRECIPITATION; PRIORITY JOURNAL; SPRAY DRYING; SUPERCRITICAL FLUID EXTRACTION;

EID: 0038094397     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-409X(03)00078-4     Document Type: Conference Paper

References (70)

1. D. Begon, P. Guillaume, M. Kohl, Process for producing fine medicinal substances, WO World IPO 0114036, 2001.
2. P. Chiesi, Conversion of an antiinflammatory steroid into a form administrable with an aerosol, Ger. Offen. DE 3018550, 1980.
3. R. Banholzer, P. Sieger, C. Kulinna, M. Trunk, M.L.A. Graulich, Crystalline triotropium bromide monohydrate, method for producing the usage as inhalant powder, WO World IPO 0230928 A1, 2002.
4. A.R. Clark, C.C. Hsu, A.J. Walsh, Preparation of sodium chloride aerosol formulations, WO World IPO 9631221 A1, 1996.
5. D. Ganderton, N.M. Kassem, Saccharides as aerosol carriers, US Pat. 5376386, 1994.
6. Larhrib H., Zeng X.M., Martin G.P., Marriott C., Pritchard J. The use of different grades of lactose as a carrier for aerosolized salbutamol sulfate. Int. J. Pharm. 191:1999;1-14.
7. Zeng X.-M., Martin G.P., Marriott C., Pritchard J. Lactose as a carrier in dry powder formulations: the influence of surface characteristics on drug delivery. J. Pharm. Sci. 90:2001;1424-1434.
8. J. Bell, Composition for treating airway diseases, US Pat. 416516, 1979.
9. K.A. Johnson, M.S. Gordon, S.W. Lyons, Methods and system for processing dispersible fine powders, US Pat. 6103270, 2000.
10. Diamant Z., Page C.P. Review - heparin and related molecules as a new treatment for asthma. Pulm. Pharmacol. Ther. 13:2000;1-4.
11. Buccellati C., Fumagalli F., Viappiani S., Folco G. Leukotriene modifiers: novel therapeutic opportunities in asthma. Farmaco. 57:2002;235-242.
12. Matzer W.J., Nyce J.W. Respirable antisense oligonucleotide (RASON) therapy for asthma. Biodrugs. 12:1999;237-243.
13. N.Y.K. Chew, H.-K. Chan, Pharmaceutical dry powder aerosols: emerging technologies, in: J. Swarbrick, J.C. Boylan (Eds.), Encyclopedia of Pharmaceutical Technology, Marcel Dekker, New York, 2002, in press.
14. Chew N.Y.K., Chan H.-K. Pharmaceutical dry powder aerosols. KONA - Powder Particles. 19:2001;46-57.
15. Vidgren M.T., Vidgren P.A., Paronen T.P. Comparison of physical and inhalation properties of spray-dried and mechanically micronized disodium cromoglycate. Int. J. Pharm. 35:1987;139-144.
16. R.B. Forrester, T.D. Boardman, Inhalation pharmaceuticals, US Pat. 4590206, 1986.
17. Chawla A., Taylor K.M.G., Newton J.M., Johnson M.C.R. Production of spray dried salbutamol sulfate for use in dry powder aerosol formulation. Int. J. Pharm. 108:1994;233-240.
18. Masters K. Spray Drying Handbook. 3rd Edition:1979;Halsted Press, New York.
19. A.J. Woolfe, X.M. Zheng, A. Langford, Method to produce powders for pulmonary or nasal administration, WO World IPO 0113885, 2001.
20. Sakagami M., Kinoshita W., Sakon K., Sato J., Makino Y. Mucoadhesive beclomethasone microspheres for powder inhalation: their pharmacokinetics and pharmacodynamics evaluation. J. Control. Release. 80:2002;207-218.
21. Dellamary L.A., Tarara T.E., Smith D.J., Woelk C.H., Adractas A., Costello M.L., Gill H., Weers J. Hollow porous particles in metered dose inhalers. Pharm. Res. 17:2000;168-174.
22. D.A. Edwards, R.P. Batycky, L. Johnston, Highly efficient delivery of a large therapeutic mass aerosol, WO World IPO 0195874 A2, 2001.
23. J. Weers, Dispersible powders for inhalation applications. Innovations in Pharm. Tech. 01 (2000) 111-112, 114-116.
24. D.A. Edwards, R.P. Batycky, L. Johnston, Highly efficient delivery of a large therapeutic mass aerosol, WO World IPO 0195874, 2001.
25. K.D. Kussendrager, M.J.H. Ellison, Carrier material for dry powder inhalation, WO World IPO 0207705, 2002.
26. Maa Y.-F., Prestrelski S.J. Curr. Pharm. Biotechnol. 1:2000;283-302.
27. D.E. Chickering III, M.J. Keegan, G. Randall, H. Bernstein, J. Straub, Spray drying method, US Pat. 6223455, 2001.
28. Mumenthaler M., Leuenberger H. Atmospheric spray-freeze drying: a suitable alternative in freeze-drying technology. Int. J. Pharm. 72:1991;97-110.
29. Maa Y.-F., Nguyen P.-A., Sweeney T., Shire S.J., Hsu C.C. Protein inhalation powders: spray drying vs. spray freeze drying. Pharm. Res. 16:1999;249-254.
30. Y.-F. Maa, P.-A. Nguyen, Method of spray freeze drying proteins for pharmaceutical administration, US Pat. 6284282, 2001.
31. W. Watanabe, P. Ahonen, E. Kauppinen, R. Jarvinen, D. Brown, J. Jokiniemi, W. Muttonen, Inhalation particles, WO World IPO 0149263, 2001.
32. Watanabe W., Ahonen P., Kauppinen E., Jarvinen R., Brown D., Jokiniemi J., Muttonen W. Novel method for the synthesis of inhalable multicomponent drug powders with controlled morphology and size. Dalby R.N., Byron P.R., Peart J., Farr S.J. Proceedings of Respiratory Drug Delivery VIII. Vol. II:2002;795-797 Davis Horwood International, North Carolina.
33. D.A.V. Morton, Method of manufacturing particles, WO World IPO 0187277, 2001.
34. R.W. Lancaster, H. Sigh, A.L. Theophilus, Apparatus and process for preparing crystalline particles. WO World IPO 0038811, 2000.
35. York P., Hanna M. Particle engineering by supercritical fluid technologies for powder inhalation drug delivery. Dalby R.N., Byron P.R., Farr S.J. Proceedings of Respiratory Drug Delivery VI:1996;231-239 Interpharm Press, Buffalo Grove, IL.
36. Sievers R.E., Sellers S.P., Clark G.S., Villa J.A., Mioskowski B., Carpenter J. Supercritical fluid carbon dioxide technologies for fine particle formation for pulmonary drug delivery. Book of Abstracts. 219th ACS National Meeting, San Francisco, CA, 26-30 March 2000:2000;American Chemical Society, Washington, DC. MSDI-173.
37. N. Vemuri, J.-R. Authelin, P. Hosek, The milling process for the production of finely milled medicinal substances, WO World IPO 0032165, 2000.
38. G.G. Liversidge, K.C. Cundy, J.F. Bishop, D.A. Czekai, Surface modified drug nanoparticles, US Pat. 5145684, 1992.
39. ®. Dalby R.N., Byron P.R., Peart J., Farr S.J. Proceedings of Respiratory Drug Delivery VII:2000;447-449 Serentec Press, North Carolina.
40. L.-E. Briggner, K. Bystrom, E. Jakupovic, E. Trofast, J. Trofast, Pharmaceutical formulation, US Pat. 5874063, 1999.
41. G. Ward, S. Dwivedi, Physically stabilized dry powder formulations, WO World IPO 0176560, 2001.
42. Lucas P., Clarke M.J., Anderson K., Tobyn M.J., Staniforth J.N. The role of fine particle excipients in pharmaceutical dry powder aerosols. Dalby R.N., Byron P.R., Farr S.J. Proceedings of Respiratory Drug Delivery VI:1996;243-250 Interpharm Press, Buffalo Grove, IL.
43. J.N. Staniforth, D.A.V. Morton, R. Musa, Method of making particles for use in a pharmaceutical composition, WO World IPO 0200197 A1, 2002.
44. J.N. Staniforth, Carrier particles for use in dry powder inhalers, US Pat. 6153224, 2000.
45. J.N. Staniforth, H. Harris, D.A.V. Morton, R. Bannister, Pharmaceutical compositions for inhalation containing magnesium stearate, WO World IPO 0243702 A2, 2002.
46. M. Keller, R. Mueller-Walz, Dry powder for inhalation, WO World IPO 0028979, 2000.
47. Keller M., Muller-Walz R., Gilchrist P., Lefrancoise G., Haeberlin B. Effect of storage on the in vitro performance of formoterol-fumarate powder blends in the SkyePharma MDPI. Dalby R.N., Byron P.R., Farr S.J., Peart J. Proceedings of Respiratory Drug Delivery VII. II:2000;511-514 Serentec Press, North Carolina.
48. J.N. Staniforth, D.A.V. Morton, R. Gill, G. Brambilla, R. Musa, L. Ferrarini, Pharmaceutical formulations for dry powder inhalers, WO World IPO 0178695 A2, 2001.
49. R. Musa, P. Ventura, P. Chiesi, Improved powdery pharmaceutical compositions for inhalation comprising low percentage lubricant, WO World IPO 0053157, 2000.
50. R. Musa, R. Bilzi, P. Ventura, P. Chiesi, Modified carrier particles for use in dry powder inhalers, WO World IPO 0053158, 2000.
51. Lucas P., Anderson K., Potter U.J., Staniforth J.N. Enhancement of small particle size drug powder aerosol formulations using an ultra low density additive. Pharm. Res. 16:1999;1643-1647.
52. Fults K.A., Miller I.F., Hickey A.J. Effect of particle morphology on emitted dose of fatty acid-treated disodium cromoglycate powder aerosols. Pharm. Dev. Technol. 2:1997;67-79.
53. J.N. Staniforth, Powders for use in dry powder pharmaceutical inhalers, WO World IPO 9703649 A1, 1997.
54. J.N. Staniforth, Carrier particles for use in dry powder inhalers, WO World IPO 9623485 A1, 1996.
55. G. Ward, Stabilized dry powder formulations, WO World IPO 0170198, 2001.
56. T. Nilsson, L. Nilsson, Medical electropowders for inhalers, WO World IPO 0211801, 2002.
57. L.G. Nilsson, Device for an inhaler, US Pat. 6089227, 2000.
58. Chan H.K., Clark A., Gonda I., Mumenthaler M., Hsu C. Spray dried powders and powder blends of recombinant human deoxyribonuclease (rhDNase) for aerosol delivery. Pharm. Res. 14:1997;431-437.
59. Chew N.Y.K., Chan H.-K. Effect of humidity on the dispersion of dry powders. Dalby R.N., Byron P.R., Peart J., Farr S.J. Respiratory Drug Delivery VII. Vol. II:2000;615-618 Serentec Press, North Carolina.
60. Yamashita C., Nishibayashi T., Akashi S., Toguchi H., Odomi M. A novel formulation of dry powder for inhalation of peptides and proteins. Dalby R.N., Byron P.R., Farr S.J. Proceedings of Respiratory Drug Delivery VI:1996;483-485 Interpharm Press, Buffalo Grove, IL.
61. D. Lechuga-Ballesteros, M.-C. Kuo, Dry powder compositions having improved dispersivity, WO World IPO 0132144, 2001.
62. Chew N.Y.K., Chan H.-K. Effect of amino acids on the dispersion of spray dried cromoglycate powders as aerosol. Dalby R.N., Byron P.R., Peart J., Farr S.J. Proceedings of Respiratory Drug Delivery VIII. Vol. II:2002;619-622 Davis Horwood International, North Carolina.
63. Chew N.Y.K., Chan H.-K. Use of solid corrugated particles to enhance powder aerosol performance. Pharm. Res. 18:2001;1570-1577.
64. Edwards D.A., Hanes J., Caponetti G., Hrkach J., Ben-Jebria A., Eskew M.L., Mintzes J., Deaver D., Lotan N., Langer R. Large porous particles for pulmonary drug delivery. Science. 276:1997;1868-1871.
65. Maa Y.-F., Nguyen P.-A., Sweeney T., Shire S.J., Hsu C.C. Protein inhalation powders: spray drying vs. spray freeze drying. Pharm. Res. 16:1999;249-254.
66. Bot A.I., Tarara T.E., Smith D.J., Bot S.R., Woods C.M., Weers J.G. Novel lipid-based hollow-porous microparticles as a platform for immunoglobulin delivery to the respiratory tract. Pharm. Res. 17:2000;275-283.
67. J.G. Weers, E.G. Schutt, L.A. Dellamary, T.E. Tarara, A. Kabalnov, Stabilized preparations for use in metered dose inhalers US Pat. 6309623, 1998.
68. Weers J.G., Tarara T.E., Gill H., English B.S., Dellamary L.A. Homodispersion technology for HFA suspensions: particle engineering to reduce dosing variance. Dalby R.N., Byron P.R., Peart J., Farr S.J. Proceedings of Respiratory Drug Delivery VII:2000;91-97 Serentec Press, North Carolina.
69. Villax P., Brito V., Steckel H. Development and performance of a new simple dry powder inhaler operating at low airflow rates. Dalby R.N., Byron P.R., Peart J., Farr S.J. Proceedings of Respiratory Drug Delivery VIII. Vol. II:2002;459-462 Davis Horwood International, North Carolina.
70. Ligotke M.W. Development and characterization of a dry powder inhaler. Dalby R.N., Byron P.R., Peart J., Farr S.J. Proceedings of Respiratory Drug Delivery VIII. Vol. II:2002;419-422 Davis Horwood International, North Carolina.